ID   PRIO_RAT                Reviewed;         254 AA.
AC   P13852; Q549H6;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   02-OCT-2024, entry version 187.
DE   RecName: Full=Major prion protein;
DE            Short=PrP;
DE   AltName: CD_antigen=CD230;
DE   Flags: Precursor;
GN   Name=Prnp; Synonyms=Prn, Prp;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=SJ/D, and Zitter; TISSUE=Liver;
RX   PubMed=7909925; DOI=10.1016/0304-3940(94)90478-2;
RA   Gomi H., Ikeda T., Kunieda T., Itohara S., Prusiner S.B., Yamanouchi K.;
RT   "Prion protein (PrP) is not involved in the pathogenesis of spongiform
RT   encephalopathy in zitter rats.";
RL   Neurosci. Lett. 166:171-174(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=Wistar; TISSUE=Liver;
RX   PubMed=8879116; DOI=10.1007/bf00369996;
RA   Saeki K., Matsumoto Y., Hirota Y., Matsumoto Y., Onodera T.;
RT   "Three-exon structure of the gene encoding the rat prion protein and its
RT   expression in tissues.";
RL   Virus Genes 12:15-20(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Brain;
RX   PubMed=10373359; DOI=10.1006/jmbi.1999.2831;
RA   Wopfner F., Weidenhofer G., Schneider R., von Brunn A., Gilch S.,
RA   Schwarz T.F., Werner T., Schatzl H.M.;
RT   "Analysis of 27 mammalian and 9 avian PrPs reveals high conservation of
RT   flexible regions of the prion protein.";
RL   J. Mol. Biol. 289:1163-1178(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 29-254.
RX   PubMed=2889848;
RA   Liao Y.-C., Tokes Z., Lim E., Lackey A., Woo C.H., Button J.D.,
RA   Clawson G.A.;
RT   "Cloning of rat 'prion-related protein' cDNA.";
RL   Lab. Invest. 57:370-374(1987).
RN   [6]
RP   PROTEIN SEQUENCE OF 209-229, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RA   Lubec G., Kang S.U., Lubec S.;
RL   Submitted (SEP-2007) to UniProtKB.
CC   -!- FUNCTION: Its primary physiological function is unclear. May play a
CC       role in neuronal development and synaptic plasticity. May be required
CC       for neuronal myelin sheath maintenance. May promote myelin homeostasis
CC       through acting as an agonist for ADGRG6 receptor. May play a role in
CC       iron uptake and iron homeostasis. Soluble oligomers are toxic to
CC       cultured neuroblastoma cells and induce apoptosis (in vitro) (By
CC       similarity). Association with GPC1 (via its heparan sulfate chains)
CC       targets PRNP to lipid rafts. Also provides Cu(2+) or Zn(2+) for the
CC       ascorbate-mediated GPC1 deaminase degradation of its heparan sulfate
CC       side chains (By similarity). {ECO:0000250|UniProtKB:P04156,
CC       ECO:0000250|UniProtKB:P04925}.
CC   -!- SUBUNIT: Monomer and homodimer. Has a tendency to aggregate into
CC       amyloid fibrils containing a cross-beta spine, formed by a steric
CC       zipper of superposed beta-strands. Soluble oligomers may represent an
CC       intermediate stage on the path to fibril formation. Copper binding may
CC       promote oligomerization. Interacts with GRB2, APP, ERI3/PRNPIP and SYN1
CC       (By similarity). Mislocalized cytosolically exposed PrP interacts with
CC       MGRN1; this interaction alters MGRN1 subcellular location and causes
CC       lysosomal enlargement (By similarity). Interacts with APP. Interacts
CC       with KIAA1191 (By similarity). Interacts with ADGRG6 (By similarity).
CC       {ECO:0000250|UniProtKB:P04156, ECO:0000250|UniProtKB:P04925}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P04156};
CC       Lipid-anchor, GPI-anchor {ECO:0000250|UniProtKB:P04156}. Golgi
CC       apparatus {ECO:0000250|UniProtKB:P04925}. Note=Targeted to lipid rafts
CC       via association with the heparan sulfate chains of GPC1. Colocates, in
CC       the presence of Cu(2+), to vesicles in para- and perinuclear regions,
CC       where both proteins undergo internalization. Heparin displaces PRNP
CC       from lipid rafts and promotes endocytosis.
CC       {ECO:0000250|UniProtKB:P04156}.
CC   -!- DOMAIN: The normal, monomeric form has a mainly alpha-helical
CC       structure. The disease-associated, protease-resistant form forms
CC       amyloid fibrils containing a cross-beta spine, formed by a steric
CC       zipper of superposed beta-strands. Disease mutations may favor
CC       intermolecular contacts via short beta strands, and may thereby trigger
CC       oligomerization. {ECO:0000250|UniProtKB:P04156}.
CC   -!- DOMAIN: Contains an N-terminal region composed of octamer repeats. At
CC       low copper concentrations, the sidechains of His residues from three or
CC       four repeats contribute to the binding of a single copper ion.
CC       Alternatively, a copper ion can be bound by interaction with the
CC       sidechain and backbone amide nitrogen of a single His residue. The
CC       observed copper binding stoichiometry suggests that two repeat regions
CC       cooperate to stabilize the binding of a single copper ion. At higher
CC       copper concentrations, each octamer can bind one copper ion by
CC       interactions with the His sidechain and Gly backbone atoms. A mixture
CC       of binding types may occur, especially in the case of octamer repeat
CC       expansion. Copper binding may stabilize the conformation of this region
CC       and may promote oligomerization. {ECO:0000250|UniProtKB:P04156}.
CC   -!- DISEASE: Note=Found in high quantity in the brain of humans and animals
CC       infected with degenerative neurological diseases such as kuru,
CC       Creutzfeldt-Jakob disease (CJD), Gerstmann-Straussler syndrome (GSS),
CC       scrapie, bovine spongiform encephalopathy (BSE), transmissible mink
CC       encephalopathy (TME), etc. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the prion family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; S69654; AAB30728.2; -; Genomic_DNA.
DR   EMBL; D50093; BAA08790.1; -; Genomic_DNA.
DR   EMBL; AF117322; AAD19993.1; -; Genomic_DNA.
DR   EMBL; BC072692; AAH72692.1; -; mRNA.
DR   EMBL; M20313; AAA41947.1; -; mRNA.
DR   PIR; A53892; A53892.
DR   RefSeq; NP_036763.1; NM_012631.2.
DR   RefSeq; XP_006235124.1; XM_006235062.3.
DR   AlphaFoldDB; P13852; -.
DR   BMRB; P13852; -.
DR   SMR; P13852; -.
DR   BioGRID; 246818; 2.
DR   STRING; 10116.ENSRNOP00000028881; -.
DR   GlyCosmos; P13852; 2 sites, No reported glycans.
DR   GlyGen; P13852; 2 sites.
DR   iPTMnet; P13852; -.
DR   PhosphoSitePlus; P13852; -.
DR   jPOST; P13852; -.
DR   PaxDb; 10116-ENSRNOP00000028881; -.
DR   Ensembl; ENSRNOT00000104185.1; ENSRNOP00000093351.1; ENSRNOG00000021259.3.
DR   Ensembl; ENSRNOT00000106614.1; ENSRNOP00000093957.1; ENSRNOG00000021259.3.
DR   Ensembl; ENSRNOT00000113525.1; ENSRNOP00000085462.1; ENSRNOG00000021259.3.
DR   Ensembl; ENSRNOT00000117610.1; ENSRNOP00000096232.1; ENSRNOG00000021259.3.
DR   Ensembl; ENSRNOT00055009443; ENSRNOP00055007259; ENSRNOG00055005843.
DR   Ensembl; ENSRNOT00055009445; ENSRNOP00055007261; ENSRNOG00055005843.
DR   Ensembl; ENSRNOT00055009447; ENSRNOP00055007263; ENSRNOG00055005843.
DR   Ensembl; ENSRNOT00060003151; ENSRNOP00060002135; ENSRNOG00060002012.
DR   Ensembl; ENSRNOT00060003152; ENSRNOP00060002136; ENSRNOG00060002012.
DR   Ensembl; ENSRNOT00060003157; ENSRNOP00060002140; ENSRNOG00060002012.
DR   Ensembl; ENSRNOT00065022695; ENSRNOP00065017592; ENSRNOG00065013804.
DR   Ensembl; ENSRNOT00065022697; ENSRNOP00065017594; ENSRNOG00065013804.
DR   Ensembl; ENSRNOT00065022703; ENSRNOP00065017600; ENSRNOG00065013804.
DR   GeneID; 24686; -.
DR   KEGG; rno:24686; -.
DR   UCSC; RGD:3410; rat.
DR   AGR; RGD:3410; -.
DR   CTD; 5621; -.
DR   RGD; 3410; Prnp.
DR   VEuPathDB; HostDB:ENSRNOG00000070982; -.
DR   eggNOG; ENOG502S2A8; Eukaryota.
DR   GeneTree; ENSGT00510000049083; -.
DR   HOGENOM; CLU_094631_0_0_1; -.
DR   InParanoid; P13852; -.
DR   OMA; QMCTTQY; -.
DR   OrthoDB; 5265139at2759; -.
DR   PhylomeDB; P13852; -.
DR   TreeFam; TF105188; -.
DR   Reactome; R-RNO-9609523; Insertion of tail-anchored proteins into the endoplasmic reticulum membrane.
DR   PRO; PR:P13852; -.
DR   Proteomes; UP000002494; Chromosome 3.
DR   Bgee; ENSRNOG00000021259; Expressed in Ammon's horn and 19 other cell types or tissues.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0030425; C:dendrite; ISO:RGD.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0005794; C:Golgi apparatus; ISO:RGD.
DR   GO; GO:0016234; C:inclusion body; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0045121; C:membrane raft; ISO:RGD.
DR   GO; GO:0005741; C:mitochondrial outer membrane; ISO:RGD.
DR   GO; GO:0031965; C:nuclear membrane; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0014069; C:postsynaptic density; IDA:ARUK-UCL.
DR   GO; GO:0098552; C:side of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0043195; C:terminal bouton; ISO:RGD.
DR   GO; GO:0001540; F:amyloid-beta binding; ISO:RGD.
DR   GO; GO:0019828; F:aspartic-type endopeptidase inhibitor activity; ISO:RGD.
DR   GO; GO:0043008; F:ATP-dependent protein binding; IPI:RGD.
DR   GO; GO:0005507; F:copper ion binding; ISS:UniProtKB.
DR   GO; GO:1903135; F:cupric ion binding; ISO:RGD.
DR   GO; GO:1903136; F:cuprous ion binding; ISO:RGD.
DR   GO; GO:0005539; F:glycosaminoglycan binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0005521; F:lamin binding; IPI:RGD.
DR   GO; GO:0046872; F:metal ion binding; ISO:RGD.
DR   GO; GO:0008017; F:microtubule binding; ISO:RGD.
DR   GO; GO:0060090; F:molecular adaptor activity; ISO:RGD.
DR   GO; GO:0140693; F:molecular condensate scaffold activity; ISO:RGD.
DR   GO; GO:0140677; F:molecular function activator activity; IEA:Ensembl.
DR   GO; GO:0002020; F:protease binding; ISO:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; ISO:RGD.
DR   GO; GO:0051087; F:protein-folding chaperone binding; IPI:RGD.
DR   GO; GO:0038023; F:signaling receptor activity; ISO:RGD.
DR   GO; GO:0044325; F:transmembrane transporter binding; IPI:RGD.
DR   GO; GO:0015631; F:tubulin binding; ISO:RGD.
DR   GO; GO:0031802; F:type 5 metabotropic glutamate receptor binding; IPI:ARUK-UCL.
DR   GO; GO:1904646; P:cellular response to amyloid-beta; ISO:RGD.
DR   GO; GO:0071280; P:cellular response to copper ion; ISO:RGD.
DR   GO; GO:0071466; P:cellular response to xenobiotic stimulus; ISO:RGD.
DR   GO; GO:0007611; P:learning or memory; IMP:RGD.
DR   GO; GO:0046007; P:negative regulation of activated T cell proliferation; ISO:RGD.
DR   GO; GO:1902992; P:negative regulation of amyloid precursor protein catabolic process; ISO:RGD.
DR   GO; GO:1902430; P:negative regulation of amyloid-beta formation; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0070885; P:negative regulation of calcineurin-NFAT signaling cascade; ISO:RGD.
DR   GO; GO:0043086; P:negative regulation of catalytic activity; IDA:ARUK-UCL.
DR   GO; GO:1902951; P:negative regulation of dendritic spine maintenance; ISO:RGD.
DR   GO; GO:0032700; P:negative regulation of interleukin-17 production; ISO:RGD.
DR   GO; GO:0032703; P:negative regulation of interleukin-2 production; ISO:RGD.
DR   GO; GO:1900272; P:negative regulation of long-term synaptic potentiation; IDA:ARUK-UCL.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; ISO:RGD.
DR   GO; GO:0050860; P:negative regulation of T cell receptor signaling pathway; ISO:RGD.
DR   GO; GO:0032689; P:negative regulation of type II interferon production; ISO:RGD.
DR   GO; GO:1990535; P:neuron projection maintenance; ISO:RGD.
DR   GO; GO:0050850; P:positive regulation of calcium-mediated signaling; ISO:RGD.
DR   GO; GO:1900451; P:positive regulation of glutamate receptor signaling pathway; ISO:RGD.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; ISO:RGD.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; ISO:RGD.
DR   GO; GO:1903078; P:positive regulation of protein localization to plasma membrane; IMP:ARUK-UCL.
DR   GO; GO:0090314; P:positive regulation of protein targeting to membrane; ISO:RGD.
DR   GO; GO:0031648; P:protein destabilization; ISO:RGD.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:1905664; P:regulation of calcium ion import across plasma membrane; ISO:RGD.
DR   GO; GO:1900449; P:regulation of glutamate receptor signaling pathway; ISO:RGD.
DR   GO; GO:0050730; P:regulation of peptidyl-tyrosine phosphorylation; ISO:RGD.
DR   GO; GO:1901379; P:regulation of potassium ion transmembrane transport; ISO:RGD.
DR   GO; GO:0032880; P:regulation of protein localization; ISO:RGD.
DR   GO; GO:1904645; P:response to amyloid-beta; ISO:RGD.
DR   GO; GO:0046686; P:response to cadmium ion; IDA:RGD.
DR   GO; GO:0046688; P:response to copper ion; IDA:RGD.
DR   GO; GO:0006979; P:response to oxidative stress; ISO:RGD.
DR   Gene3D; 1.10.790.10; Prion/Doppel protein, beta-ribbon domain; 1.
DR   InterPro; IPR000817; Prion.
DR   InterPro; IPR036924; Prion/Doppel_b-ribbon_dom_sf.
DR   InterPro; IPR022416; Prion/Doppel_prot_b-ribbon_dom.
DR   InterPro; IPR025860; Prion_N_dom.
DR   PANTHER; PTHR15506; DOPPEL PRION; 1.
DR   PANTHER; PTHR15506:SF2; MAJOR PRION PROTEIN; 1.
DR   Pfam; PF00377; Prion; 1.
DR   Pfam; PF11587; Prion_bPrPp; 1.
DR   PRINTS; PR00341; PRION.
DR   SMART; SM00157; PRP; 1.
DR   SUPFAM; SSF54098; Prion-like; 1.
DR   PROSITE; PS00291; PRION_1; 1.
DR   PROSITE; PS00706; PRION_2; 1.
PE   1: Evidence at protein level;
KW   Amyloid; Cell membrane; Copper; Direct protein sequencing; Disulfide bond;
KW   Glycoprotein; Golgi apparatus; GPI-anchor; Lipoprotein; Membrane;
KW   Metal-binding; Prion; Reference proteome; Repeat; Signal; Zinc.
FT   SIGNAL          1..28
FT                   /evidence="ECO:0000255"
FT   CHAIN           29..231
FT                   /note="Major prion protein"
FT                   /id="PRO_0000025723"
FT   PROPEP          232..254
FT                   /note="Removed in mature form"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000025724"
FT   REPEAT          51..59
FT                   /note="1"
FT   REPEAT          60..67
FT                   /note="2"
FT   REPEAT          68..75
FT                   /note="3"
FT   REPEAT          76..83
FT                   /note="4"
FT   REPEAT          84..91
FT                   /note="5"
FT   REGION          23..231
FT                   /note="Interaction with GRB2, ERI3 and SYN1"
FT                   /evidence="ECO:0000250|UniProtKB:P04925"
FT   REGION          23..38
FT                   /note="Interaction with ADGRG6"
FT                   /evidence="ECO:0000250|UniProtKB:P04925"
FT   REGION          24..107
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          51..91
FT                   /note="5 X 8 AA tandem repeats of P-H-G-G-G-W-G-Q"
FT   COMPBIAS        36..54
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        90..105
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         61
FT                   /ligand="Cu(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29036"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P04156"
FT   BINDING         62
FT                   /ligand="Cu(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29036"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P04156"
FT   BINDING         63
FT                   /ligand="Cu(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29036"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P04156"
FT   BINDING         69
FT                   /ligand="Cu(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29036"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P04156"
FT   BINDING         70
FT                   /ligand="Cu(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29036"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P04156"
FT   BINDING         71
FT                   /ligand="Cu(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29036"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P04156"
FT   BINDING         77
FT                   /ligand="Cu(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29036"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:P04156"
FT   BINDING         78
FT                   /ligand="Cu(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29036"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:P04156"
FT   BINDING         79
FT                   /ligand="Cu(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29036"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:P04156"
FT   BINDING         85
FT                   /ligand="Cu(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29036"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000250|UniProtKB:P04156"
FT   BINDING         86
FT                   /ligand="Cu(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29036"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000250|UniProtKB:P04156"
FT   BINDING         87
FT                   /ligand="Cu(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29036"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000250|UniProtKB:P04156"
FT   LIPID           231
FT                   /note="GPI-anchor amidated serine"
FT                   /evidence="ECO:0000250|UniProtKB:P04273"
FT   CARBOHYD        181
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000305"
FT   CARBOHYD        197
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000305"
FT   DISULFID        179..214
FT                   /evidence="ECO:0000250|UniProtKB:P04273"
SQ   SEQUENCE   254 AA;  27804 MW;  28F424D13BEFA2C6 CRC64;
     MANLGYWLLA LFVTTCTDVG LCKKRPKPGG WNTGGSRYPG QGSPGGNRYP PQSGGTWGQP
     HGGGWGQPHG GGWGQPHGGG WGQPHGGGWS QGGGTHNQWN KPSKPKTNLK HVAGAAAAGA
     VVGGLGGYML GSAMSRPMLH FGNDWEDRYY RENMYRYPNQ VYYRPVDQYS NQNNFVHDCV
     NITIKQHTVT TTTKGENFTE TDVKMMERVV EQMCVTQYQK ESQAYYDGRR SSAVLFSSPP
     VILLISFLIF LIVG
//
